EP0780157A1 - Complexe de ruthénium avec des ligands phosphinoxazoline chiral et bidentés pour l'hydrogénation transfert énantiosélective des cetones prochirales - Google Patents

Complexe de ruthénium avec des ligands phosphinoxazoline chiral et bidentés pour l'hydrogénation transfert énantiosélective des cetones prochirales Download PDF

Info

Publication number
EP0780157A1
EP0780157A1 EP96120522A EP96120522A EP0780157A1 EP 0780157 A1 EP0780157 A1 EP 0780157A1 EP 96120522 A EP96120522 A EP 96120522A EP 96120522 A EP96120522 A EP 96120522A EP 0780157 A1 EP0780157 A1 EP 0780157A1
Authority
EP
European Patent Office
Prior art keywords
alkyl
aryl
group
general formula
complexes according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP96120522A
Other languages
German (de)
English (en)
Other versions
EP0780157B1 (fr
Inventor
Guenther Helmchen
Thomas Langer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of EP0780157A1 publication Critical patent/EP0780157A1/fr
Application granted granted Critical
Publication of EP0780157B1 publication Critical patent/EP0780157B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/143Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of ketones
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/18Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms
    • B01J31/189Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes containing nitrogen, phosphorus, arsenic or antimony as complexing atoms, e.g. in pyridine ligands, or in resonance therewith, e.g. in isocyanide ligands C=N-R or as complexed central atoms containing both nitrogen and phosphorus as complexing atoms, including e.g. phosphino moieties, in one at least bidentate or bridging ligand
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60Reduction reactions, e.g. hydrogenation
    • B01J2231/64Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/643Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of R2C=O or R2C=NR (R= C, H)
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82Metals of the platinum group
    • B01J2531/821Ruthenium
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Definitions

  • the present invention relates to chiral ruthenium complexes of the general formula (I) RuX 1 X 2 L 1 L 2 (I) with a chiral ligand L 2 , which are suitable for the enantioselective transfer hydrogenation of prochiral ketones.
  • catalytically active complexes In addition to catalytic hydrogenation with hydrogen, enantioselective transfer hydrogenation in the presence of chiral rhodium and ruthenium complexes is common.
  • the catalytically active complexes generally also contain diphosphine ligands which are difficult to produce. In addition, only a moderate enantiomeric excess can be achieved using these complexes. For example, Genêt et al. (Synlett 1993, 478) a ruthenium complex with a chiral diphosphine ligand, which at best yields an enantiomeric excess of 62% (ee) in the transfer hydrogenation of acetophenone.
  • the object of the invention is therefore to provide a better catalyst for the transfer hydrogenation of prochiral ketones.
  • the catalyst should be easily accessible, ensure high enantioselectivity and be useful for the reduction of all types of ketones.
  • alkyl means a straight-chain or branched alkyl group with preferably 1 to 6 and in particular 1 to 4 carbon atoms.
  • alkyl groups are methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, sec-butyl and t-butyl.
  • Cycloalkyl preferably means C 5 -C 8 cycloalkyl and in particular cyclopentyl and cyclohexyl.
  • Aromatic or aryl represents benzene, naphthalene or phenyl, ⁇ - or ⁇ -naphthyl.
  • C 1 -C 4 alkyl-substituted aromatics are, for example, toluene, mesitylene or p-cymene.
  • the heteroaryl groups are preferably 5- or 6-membered heteroaromatics with one or two nitrogen atoms, which may contain further aromatics condensed on. Examples are pyrrolyl, imidazolyl, pyridyl, pyrimidyl, indolyl, quinolinyl etc.
  • An aralkyl or heteroaralkyl group represents a monovalent radical in which a C 1 -C 4 alkylene chain carries an aryl or heteroaryl group.
  • Acyl represents RCO, where R in particular represents H or C 1 -C 4 alkyl.
  • the C 1 -C 10 carboxylic acids whose anions can be used as ligand X 1 or X 2 in the complex according to the invention are linear or branched alkane carboxylic acids which may have 1, 2 or 3 chlorine or fluorine atoms or corresponding ones Derivatives of benzoic acid or naphthoic acid.
  • Preferred Complexes are those in which X 1 or X 2 independently of one another represent halide, in particular chloride, bromide and / or iodide or the anion of a C 1 -C 4 -carboxylic acid, in particular acetate, propionate and / or butyrate.
  • X 1 and X 2 together can represent the dianion of a 1,3-, 1,4- or 1,5-dicarboxylic acid. This includes derivatives of malonic acid, succinic acid or glutaric acid.
  • Preferred ligands L 1 in the complexes according to the invention having the formula (I) are CO, PF 3 and 1,5-cyclooctadiene and phosphine ligands of the general formula (II) in which the groups R 1 , R 2 and R 3 are preferably, independently of one another, for linear or branched C 1 -C 4 alkyl groups or phenyl groups which are optionally substituted by 1, 2 or 3 C 1 -C 4 alkyl groups.
  • n-propyl methyl, ethyl, n-propyl, i-propyl, n-butyl and i-butyl or phenyl, ortho- or para-tolyl, para-isopropylphenyl or mesityl.
  • Very particularly preferred complexes contain as ligands L 1 triphenylphosphine, tri-C 1 -C 4 alkylphosphine, tritolylphosphine or trimesitylphosphine.
  • the groups R 4 and R 5 independently of one another are preferably C 1 -C 4 -alkyl, in particular branched C 1 -C 4 -alkyl, or aryl which may be replaced by 1, 2 or 3 C 1 -C 4 alkyl groups is substituted.
  • R 4 and R 5 are particularly preferably independently of one another methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, phenyl, ortho- or para-tolyl, mesityl, ⁇ - or ⁇ -naphthyl. If R 4 and R 5 form a heterocyclic ring together with the P atom to which they are attached, then R 4 and R 5 preferably together represent n-butylene, n-pentylene or 2,2'-biphenylene.
  • R 6 represents methyl, ethyl, propyl, i-propyl, n-butyl, 2-butyl, i-butyl, t-butyl, phenyl and benzyl and particularly preferably i-propyl and t-butyl.
  • Atoms or groups for R 7 which are preferred according to the invention are hydrogen, methyl or phenyl and particularly preferably hydrogen.
  • the absolute configuration of the carbon atoms in the oxazoline part which carry the substituents R 6 and R 7 can be (R) or (S) independently of one another. According to the invention, only those ligands L 2 are suitable in which the configuration on the C atom which carries R 6 is uniform (R) or (S).
  • the ligand L 2 is particularly preferably a compound of the formulas (IIIa), (IIIb) or (IIIc) with (R) or (S) configuration on the C atom which bears the alkyl group.
  • the ligands L 2 according to the invention are known or can be prepared analogously to known methods. They are prepared, for example, starting from chiral amino alcohols of the general formula (V) by means of an acid catalysis ring closure reaction with o-fluoroaryl nitriles of the general formula (VI) to give the chiral 2- (o-fluoroaryl) oxazoline derivatives of the general formula (VII) (Bolm et al , Chem. Ber. 1991, 124, 1173). These can then be converted with a suitably substituted phosphine anion to the desired ligand L 2 of the general formula (III) (Williamson et al, Synlett, 1993, 509).
  • the complexes according to the invention are prepared by reacting a chiral ligand of the general formula (III) with a precursor complex of the formula RuX 1 X 2 L 1 L 2 L 3 , in which X 1 , X 2 and L 1 have the meaning indicated above, L 2 and L 3 are identical or different and are selected from CO, aromatics, which may have 1, 2 or 3 alkyl substituents, in particular p-cymene, dienes, in particular 1,5-cyclooctadiene (COD), or triarylphosphines, in particular triphenylphosphine.
  • the ligands L 2 and L 3 may be absent, especially if the precursor complexes are in dimeric or oligomeric form.
  • Suitable complexes are, for example, RuCl 2 (PPh 3 ) 3 , [RuCl 2 (p-cymene)] 2 , [RuCl 2 (COD)] x , [RuCl 2 (CO) 3 ] 2 .
  • the reaction is carried out in an inert solvent, for example an aromatic which optionally carries 1, 2 or 3 C 1 -C 4 -alkyl substituents or chlorine atoms, preferably benzene, toluene, ethylbenzene, p-cymene, chlorobenzene, dichlorobenzene, or an ether, preferably Diethyl ether, tetrahydrofuran, methyl t-butyl ether, anisole, or a haloalkane, for example dichloromethane, chloroform, dichloroethane, trichloroethane, at temperatures in the range from 0 ° C. to 150 ° C., preferably from 10 ° C. to 100 ° C., particularly preferred at room temperature.
  • an inert solvent for example an aromatic which optionally carries 1, 2 or 3 C 1 -C 4 -alkyl substituents or chlorine atoms, preferably benzene, toluen
  • R and R ' are prochiral ketones and the transfer hydrogenation catalyzed by the complexes according to the invention to the corresponding alcohols is enantioselective.
  • the enantiomeric excess is more than 60% (ee), preferably more than 90% (ee).
  • radicals R and R ' There are in principle no restrictions with regard to the type of radicals R and R '. They stand independently of one another for straight-chain or branched alkyl, aryl, (hetero) aryl or (hetero) aralkyl groups, it being possible for all groups in turn to have further groups such as alkyl, (hetero) aryl or (hetero) aralkyl groups.
  • One of the radicals R and R ' is preferably an aryl or heteroaryl group.
  • the carbonyl function to be reduced can also be built into a mono- or polycyclic ring structure.
  • the radicals R and R 'can have functional groups independently of one another.
  • the process according to the invention for enantioselective transfer hydrogenation of prochiral ketones is usually carried out by reacting the ketone with a hydrogen donor, preferably a secondary alcohol, in particular i-propanol, 2-butanol, cyclopentanol or cyclohexanol, especially i-propanol, in the presence of catalytic amounts of one or more the complexes according to the invention and catalytic amounts of a base.
  • the catalysts are used in amounts of 0.001 to 10 mol% per carbonyl function to be reduced, preferably 0.01 to 1 mol%, in particular 0.05 to 0.5 mol%.
  • the amount of base, based on the catalyst, is in the range of 0.5-100 mol equivalents, preferably 1-50 mol-eq., In particular 5-30 mol-eq.
  • Suitable bases are alkali metal hydroxides, alkali metal C 1 -C 4 alcoholates, alkali metal hydrides or calcium hydride. Alkali metal hydroxides or alcoholates are preferably used.
  • the reaction can be carried out in the secondary alcohol, if it is liquid, as a solvent.
  • cosolvents can be used, preferably ethers such as diethyl ether, tetrahydrofuran, methyl t-butyl ether, dioxane, pyran or hydrocarbons, light petroleum fractions, preferably hexane, and chlorinated hydrocarbons, for example dichloromethane or chloroform.
  • the reaction is carried out in the range from -30 ° C to 150 ° C, preferably 20 ° C to 100 ° C, and, if the solvent has a lower boiling temperature, under pressure.
  • the reaction time is in the range of 15 min. until 12 h.
  • the reaction mixture is worked up in a conventional manner, and the product is obtained, for example, by distillation or crystallization.
  • a ruthenium complex according to the invention is generated from a suitable ruthenium precursor complex and a ligand L 2 of the general formula (III) in an inert solvent, for example one of the cosolvents mentioned, and then the prochiral ketone, the secondary Alcohol and the base are added and the mixture is reacted.
  • the transfer hydrogenation can be carried out using an in situ catalyst prepared from one of Examples 1 to 5 as follows.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
EP96120522A 1995-12-22 1996-12-19 Complexe de ruthénium avec des ligands phosphinoxazoline chiral et bidentés pour l'hydrogénation transfert énantiosélective des cetones prochirales Expired - Lifetime EP0780157B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19548399A DE19548399A1 (de) 1995-12-22 1995-12-22 Rutheniumkomplexe mit einem chiralen, zweizähnigen Phosphinoxazolin-Liganden zur enantioselektiven Transferhydrierung von prochiralen Ketonen
DE19548399 1995-12-22

Publications (2)

Publication Number Publication Date
EP0780157A1 true EP0780157A1 (fr) 1997-06-25
EP0780157B1 EP0780157B1 (fr) 2002-04-03

Family

ID=7781187

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96120522A Expired - Lifetime EP0780157B1 (fr) 1995-12-22 1996-12-19 Complexe de ruthénium avec des ligands phosphinoxazoline chiral et bidentés pour l'hydrogénation transfert énantiosélective des cetones prochirales

Country Status (5)

Country Link
US (1) US5693820A (fr)
EP (1) EP0780157B1 (fr)
JP (1) JP3878703B2 (fr)
CA (1) CA2192226C (fr)
DE (2) DE19548399A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024410A1 (fr) * 1997-11-12 1999-05-20 The Penn State Research Foundation Reactions catalysees par des metaux de transition basees sur des ligands d'amine-oxazolinyle chiraux
WO2002022526A2 (fr) * 2000-09-13 2002-03-21 Firmenich S.A. Procedes d'hydrogenation catalytique
WO2003014133A1 (fr) * 2001-08-09 2003-02-20 Ciba Specialty Chemicals Holding Inc. Derives d'isoxazoline sous forme de p, n ligands

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706321D0 (en) * 1997-03-26 1997-05-14 Zeneca Ltd Catalytic hydrogenation
US6472533B1 (en) * 1999-04-08 2002-10-29 The Texas A & M University System Ligands for chiral catalysis
ES2407033T3 (es) 2007-05-04 2013-06-11 Mallinckrodt Llc Procedimientos mejorados para la preparación de opiáceos 6-alfa-hidroxi-n-alquilados
AU2008276385B2 (en) * 2007-07-17 2013-07-18 SpecGx LLC Preparation of N-alkylated opiates by reductive amination
AU2009300392B2 (en) * 2008-09-30 2014-10-23 SpecGx LLC Processes for the selective amination of ketomorphinans
US8946419B2 (en) 2009-02-23 2015-02-03 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
EP2440561B1 (fr) 2009-06-11 2014-04-30 Mallinckrodt LLC Amination reductrice de 6-ceto normorphinanes par transfert catalytique d'hydrogene
US8519133B2 (en) * 2009-06-11 2013-08-27 Mallinckrodt Llc Preparation of 6-alpha-amino N-substituted morphinans by catalytic hydrogen transfer
US8431705B2 (en) 2009-09-24 2013-04-30 Mallinckrodt Llc One-pot preparation of hexahydroisoquinolines from amides
US8415474B2 (en) * 2009-09-24 2013-04-09 Mallinckrodt Llc One-pot preparation of hexahydroisoquinolines from dihydroisoquinolines
US9296699B2 (en) 2011-06-09 2016-03-29 Mallinckrodt Llc Reductive amination of 6-keto morphinans by catalytic hydrogen transfer
BR112014005421A2 (pt) 2011-09-08 2017-04-04 Mallinckrodt Llc produção de alcaloides sem o isolamento de intermediários
US20180030074A1 (en) * 2014-11-05 2018-02-01 Shozo Furumoto Phosphonium compound and production method therefor
WO2023153494A1 (fr) * 2022-02-14 2023-08-17 国立大学法人 東京大学 Catalyseur, procédé de production de formamides et/ou d'amines, procédé de production de formamides et/ou d'alcools, et complexe

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271311A2 (fr) * 1986-12-09 1988-06-15 Takasago International Corporation Complexes ruthénium-phosphine
EP0366390A2 (fr) * 1988-10-24 1990-05-02 Takasago International Corporation Complexes ruthénium-phosphine
EP0386833A1 (fr) * 1989-03-03 1990-09-12 Shell Internationale Researchmaatschappij B.V. Système catalytique pour carbonylation
EP0478147A1 (fr) * 1990-08-30 1992-04-01 Takasago International Corporation Procédé pour la préparation des dérivés de gamma-butyrolactone optiquement actifs
FR2693190A1 (fr) * 1992-07-02 1994-01-07 Elf Aquitaine Procédé d'hydrogénation énantiosélectif de la double liaison C=O OXO.
DE4243030A1 (de) * 1992-12-18 1994-06-23 Basf Ag Iminverbindungen

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0271311A2 (fr) * 1986-12-09 1988-06-15 Takasago International Corporation Complexes ruthénium-phosphine
EP0366390A2 (fr) * 1988-10-24 1990-05-02 Takasago International Corporation Complexes ruthénium-phosphine
EP0386833A1 (fr) * 1989-03-03 1990-09-12 Shell Internationale Researchmaatschappij B.V. Système catalytique pour carbonylation
EP0478147A1 (fr) * 1990-08-30 1992-04-01 Takasago International Corporation Procédé pour la préparation des dérivés de gamma-butyrolactone optiquement actifs
FR2693190A1 (fr) * 1992-07-02 1994-01-07 Elf Aquitaine Procédé d'hydrogénation énantiosélectif de la double liaison C=O OXO.
DE4243030A1 (de) * 1992-12-18 1994-06-23 Basf Ag Iminverbindungen

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
GENET ET AL., SYNLETT., 1993, pages 478
MATHIEU ET AL., J. CHEM. SOC. CHEM. COMM., 1995, pages 1721
NOYORI ET AL., J. AM. CHEM. SOC., vol. 117, 1995, pages 7562

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999024410A1 (fr) * 1997-11-12 1999-05-20 The Penn State Research Foundation Reactions catalysees par des metaux de transition basees sur des ligands d'amine-oxazolinyle chiraux
US6255493B1 (en) 1997-11-12 2001-07-03 The Penn State Research Foundation Transition metal-catalyzed reactions based on chiral amine oxazolinyl ligands
US6451727B2 (en) 1997-11-12 2002-09-17 The Penn State Research Foundation Catalysts for use in asymmetric synthesis comprising transition metals and chiral amine oxazolinyl ligands
WO2002022526A2 (fr) * 2000-09-13 2002-03-21 Firmenich S.A. Procedes d'hydrogenation catalytique
WO2002022526A3 (fr) * 2000-09-13 2003-09-12 Firmenich & Cie Procedes d'hydrogenation catalytique
WO2003014133A1 (fr) * 2001-08-09 2003-02-20 Ciba Specialty Chemicals Holding Inc. Derives d'isoxazoline sous forme de p, n ligands
US7081536B2 (en) 2001-08-09 2006-07-25 Ciba Specialty Chemicals Corporation Isoxazoline derivatives as P N ligands

Also Published As

Publication number Publication date
CA2192226C (fr) 2005-04-19
CA2192226A1 (fr) 1997-06-23
US5693820A (en) 1997-12-02
EP0780157B1 (fr) 2002-04-03
JP3878703B2 (ja) 2007-02-07
JPH09249677A (ja) 1997-09-22
DE19548399A1 (de) 1997-06-26
DE59609005D1 (de) 2002-05-08

Similar Documents

Publication Publication Date Title
DE60306795T2 (de) Ruthenium-komplexe als (pre)katalysatoren für metathesereaktionen
EP0780157B1 (fr) Complexe de ruthénium avec des ligands phosphinoxazoline chiral et bidentés pour l'hydrogénation transfert énantiosélective des cetones prochirales
DE69634639T2 (de) Verfahren zur herstellung optische aktive verbindungen
DE2424543C2 (de) Chlor-Rhodium-Komplexe mit einem stereoisomeren Diphosphin-Liganden, ihre Herstellung und ihre Verwendung bei der asymmetrischen Hydrierung
EP1802561B1 (fr) Procede pour preparer des composes de carbonyle optiquement actifs
EP0643065B1 (fr) Nouvelles bisphosphines pour catalyseurs d'hydrogénation asymétrique
EP0646590B1 (fr) Ferrocényldiphosphines substituées par un groupe fluoroalkyle comme ligands pour des catalyseurs homogènes
DE19717359B4 (de) Bisphosphitverbindungen und Verfahren zu deren Herstellung
EP2459579B1 (fr) Composés phosphine-borane contenant des groupes imidazole et procédé de production de composés phosphorés contenant des groupes imidazole
EP0301457A2 (fr) Procédé de préparation d'amines secondaires optiquement actives
WO2008132057A1 (fr) Procédé pour produire des composés carbonyle optiquement actifs
EP0582692B1 (fr) Ligands diphosphiniques
EP0583433B1 (fr) Ligands diphosphiniques
EP3994117A1 (fr) Hydrogénation d'esters en vue d'obtenir des alcools en présence d'un complexe de ru-pnn
DE602004008478T2 (de) Biphosphinrutheniumkomplexe mit chiralen diaminliganden als katalysatoren
DE60102587T2 (de) Chirale ligande für asymmetrische katalysatoren
EP0218970A2 (fr) Complexes chiraux de rhodium et de diphosphines pour l'hydrogénation catalytique
EP0744401B1 (fr) Procédé pour la préparation des dérivés de l'acide 2-pipérazinique optiquement actif
EP1161437B1 (fr) Composes de phosphabenzol et leur utilisation comme ligands de catalyseurs d'hydroformylation
DE4001019A1 (de) Verfahren zur asymmetrischen hydrierung von (alpha)-ketocarbonylverbindungen zu optisch aktiven (alpha)-hydroxycarbonylverbindungen
EP0512415B1 (fr) Procédé pour la préparation enantiosélective des dérivés de 2(R) benzyl succinamide
EP0749953A1 (fr) Préparation d'acides alpha-halogénocarboxyliques chiraux
DE10148712A1 (de) Diphosphin
DE69914889T2 (de) Asymmetrische hydrierung
DE19706273A1 (de) Verfahren zur Herstellung optisch aktiver gamma-Butyrolactame und -lactone

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): CH DE ES FR GB IT LI NL

17P Request for examination filed

Effective date: 19971203

17Q First examination report despatched

Effective date: 19991029

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): CH DE ES FR GB IT LI NL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20020403

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: SCHMAUDER & PARTNER AG PATENTANWALTSBUERO

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 59609005

Country of ref document: DE

Date of ref document: 20020508

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 20020614

ET Fr: translation filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20021030

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20030106

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20081203

Year of fee payment: 13

Ref country code: CH

Payment date: 20081230

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20081212

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20081211

Year of fee payment: 13

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20081217

Year of fee payment: 13

REG Reference to a national code

Ref country code: CH

Ref legal event code: PCAR

Free format text: SCHMAUDER & PARTNER AG PATENT- UND MARKENANWAELTE VSP;ZWAENGIWEG 7;8038 ZUERICH (CH)

REG Reference to a national code

Ref country code: NL

Ref legal event code: V1

Effective date: 20100701

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20091219

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20100831

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100701

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091231

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091231

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20100701

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091219